Researchers studied 47,199 patients with cardiovascular disease who received Novo Nordisks GLP-1 drug semaglutide, sold as Ozempic for diabetes and Wegovy for obesity, for up to two years
These changes included mucosal erosion, ulcerative lesions, deformation and distortion of colonic recesses, extensive infiltration of inflammatory cells (primarily lymphocytes and neutrophils) in the mucosa and submucosa, and depletion of goblet cells
PMCID: PMC5872767
Rachelle Alterman (Technion - Israel Institute of Technology) 81 Land Policies in Europe - Land-use planning, property rights, and spatial development In many European countries, land-use planning is facing increasing and oftentimes contradictory challenges
At the Perito Clinic, were dedicated to helping patients with every facet of their lives
The immense scale of GLP-1 prescribing opens up a number of opportunities for well-powered retrospective research on narrowly targeted questions and rare events